BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6535646)

  • 41. In vivo diffusion chamber culture reduces the tumorigenicity of PCC4-aza1 teratocarcinoma cells.
    Nomura T; Kameyama T
    Cancer Lett; 1987 Jan; 34(1):21-6. PubMed ID: 3802066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus.
    Rembecki RM; Kumar V; David CS; Bennett M
    Immunogenetics; 1988; 28(3):158-70. PubMed ID: 2457549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex.
    Ostrand-Rosenberg S; Nickerson DA; Clements VK; Garcia EP; Lamouse-Smith E; Hood L; Stroynowski I
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5084-8. PubMed ID: 2740345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of transplantable teratocarcinoma in mice.
    Thakare AV; Chitale AR; Lalitha VS
    Indian J Exp Biol; 1985 Mar; 23(3):131-3. PubMed ID: 4054953
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of homologous homeo-box-containing genes in differentiated human teratocarcinoma cells and mouse embryos.
    Hauser CA; Joyner AL; Klein RD; Learned TK; Martin GR; Tjian R
    Cell; 1985 Nov; 43(1):19-28. PubMed ID: 4075393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.
    Swartzendruber DE; Lehman JM
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):179-87. PubMed ID: 164473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Participation of teratocarcinoma cells in mouse embryo development.
    Brinster RL
    Cancer Res; 1976 Sep; 36(9 PT 2):3412-4. PubMed ID: 788901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC-unrestricted T-cell cytotoxicity against tumour cells.
    Sponaas AM; Loveland B; Simpson E
    Immunology; 1988 Feb; 63(2):233-9. PubMed ID: 3258274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs.
    Ellman L; Green I; Benacerraf B
    J Immunol; 1971 Aug; 107(2):382-8. PubMed ID: 5568769
    [No Abstract]   [Full Text] [Related]  

  • 51. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implication of the H-2L locus in hybrid histocompatibility (Hh-1).
    Morgan GM; McKenzie IF
    Transplantation; 1981 Jun; 31(6):417-22. PubMed ID: 7020179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allograft reaction against H-2-region antigens.
    Klein J
    Transplant Proc; 1977 Mar; 9(1):847-52. PubMed ID: 17202
    [No Abstract]   [Full Text] [Related]  

  • 54. Primitive teratocarcinoma cells express a differentiation antigen specified by a gene at the T-locus in the mouse.
    Artzt K; Bennett D; Jacob F
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):811-4. PubMed ID: 4522792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro.
    Andrews PW; Damjanov I; Simon D; Banting GS; Carlin C; Dracopoli NC; Føgh J
    Lab Invest; 1984 Feb; 50(2):147-62. PubMed ID: 6694356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors.
    Marrero I; Benvenutti LA; Kalil J; Coelho V
    Immunology; 2005 Aug; 115(4):484-94. PubMed ID: 16011517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of H-2 mutations of mice: analysis of mutation 504 by the method of F1 hybrids.
    Shumova TE; Kryshkina VP; Egorov IK
    Sov Genet; 1974 Nov; 8(12):1604-6. PubMed ID: 4616341
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenetic analysis of H-2 mutations. IV. Mapping of and immune reactions to the H-2fa mutation.
    Klein J; Egorov IK; Mnatsakanyan YA; Hauptfeld V
    Scand J Immunol; 1976; 5(5):521-8. PubMed ID: 8831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.